RadioNano Therapeutics
Kyoto
About RadioNano Therapeutics
RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹Γü░B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $4.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: radionano-tx.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/radionano-therapeutics-9932 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.